Effect of Adherence to Protocolized Targeted Intensifications of Disease-modifying Antirheumatic Drugs on Treatment Outcomes in Rheumatoid Arthritis: Results from an Australian Early Arthritis Cohort

Wabe Nasir T.; Sorich Michael J.; Wechalekar Mihir D.; Cleland Leslie G.; McWilliams Leah; Lee Anita T. Y.; Spargo Llewellyn D.; Metcalf Robert G.; Hall Cindy; Proudman Susanna M.; Wiese Michael D.

首页> 外文期刊>The Journal of rheumatology >Effect of Adherence to Protocolized Targeted Intensifications of Disease-modifying Antirheumatic Drugs on Treatment Outcomes in Rheumatoid Arthritis: Results from an Australian Early Arthritis Cohort

【24h】

Effect of Adherence to Protocolized Targeted Intensifications of Disease-modifying Antirheumatic Drugs on Treatment Outcomes in Rheumatoid Arthritis: Results from an Australian Early Arthritis Cohort

机译：坚持遵守协议规定的靶向治疗疾病的抗风湿药物对类风湿关节炎治疗效果的影响：来自澳大利亚早期关节炎队列的结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective. To investigate the association between adherence to treat-to-target (T2T) protocol and disease activity, functional outcomes, and radiographic outcomes in early rheumatoid arthritis (RA).

机译：目的。调查依从治疗目标（T2T）协议与疾病活动，功能结局和早期风湿性关节炎（RA）的放射学结果之间的关联。

著录项

来源
《The Journal of rheumatology》 |2016年第9期|共7页
作者
Wabe Nasir T.; Sorich Michael J.; Wechalekar Mihir D.; Cleland Leslie G.; McWilliams Leah; Lee Anita T. Y.; Spargo Llewellyn D.; Metcalf Robert G.; Hall Cindy; Proudman Susanna M.; Wiese Michael D.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词
TREAT TO TARGET; CLINICAL GUIDELINES; PHYSICIAN ADHERENCE; TREATMENT PROTOCO;

机译：治疗至目标;临床指南;医师依从性;治疗方案;

相似文献

外文文献
中文文献
专利

1. Effect of Adherence to Protocolized Targeted Intensifications of Disease-modifying Antirheumatic Drugs on Treatment Outcomes in Rheumatoid Arthritis: Results from an Australian Early Arthritis Cohort [J] . Wabe Nasir T., Sorich Michael J., Wechalekar Mihir D., The Journal of rheumatology . 2016,第9期

机译：坚持遵守协议规定的靶向治疗疾病的抗风湿药物对类风湿关节炎治疗效果的影响：来自澳大利亚早期关节炎队列的结果
2. Comparative effectiveness of treatment with the first TNF antagonist in monotherapy, the first TNF antagonist plus one conventional synthetic disease-modifying antirheumatic drug, and the first TNF antagonist plus two or more conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis [J] . Blanca Hernández-Cruz, Esther Márquez-Saavedra, Rafael Caliz-Caliz, Arthritis research & therapy. . 2016,第1期

机译：在类风湿性关节炎患者中，第一种TNF拮抗剂在单一疗法，第一种TNF拮抗剂加一种常规的合成疾病缓解性抗风湿药和第一种TNF拮抗剂加两种或更多种常规的改善疾病的抗风湿性药物的单一治疗中的比较疗效
3. Adalimumab, etanercept, infliximab,certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation [J] . Stevenson?M, Archer?R, Tosh?J, Health technology assessment: HTA . 2016,第35期

机译：阿达木单抗，依那西普，英夫利昔单抗，赛妥珠单抗，聚乙二醇，戈利木单抗，托珠单抗和阿巴西普用于治疗类风湿性关节炎，以前未使用可改变疾病的抗风湿药治疗，且仅在常规可改变疾病的抗风湿药治疗后：系统评价和经济评价
4. Macrophage-targeted Drug Delivery System for the Treatment of Rheumatoid Arthritis [C] . Amanda Pentecost, Minju Kim, Sangmin Jeon, Society for Biomaterials annual meeting and exposition . 2017

机译：针对巨噬细胞的类风湿关节炎药物递送系统
5. The relationship between health literacy, health knowledge and adherence to treatment in patients with rheumatoid arthritis. [D] . Quinlan, Patricia. 2009

机译：类风湿关节炎患者健康素养，健康知识与坚持治疗之间的关系。
6. Comparative effectiveness of treatment with the first TNF antagonist in monotherapy the first TNF antagonist plus one conventional synthetic disease-modifying antirheumatic drug and the first TNF antagonist plus two or more conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis [O] . Blanca Hernández-Cruz, Esther Márquez-Saavedra, Rafael Caliz-Caliz, 2016

机译：在类风湿性关节炎患者中第一种TNF拮抗剂在单一疗法第一种TNF拮抗剂加一种常规的合成疾病缓解性抗风湿药和第一种TNF拮抗剂加两种或多种常规合成的疾病缓解性风湿性药物治疗中的比较疗效
7. Comparative effectiveness of treatment with the first TNF antagonist in monotherapy, the first TNF antagonist plus one conventional synthetic disease-modifying antirheumatic drug, and the first TNF antagonist plus two or more conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis [O] . Blanca Hernández-Cruz, Esther Márquez-Saavedra, Rafael Caliz-Caliz, 2016

机译：在类风湿性关节炎患者中，第一种TNF拮抗剂在单一疗法，第一种TNF拮抗剂加一种常规的合成疾病缓解性抗风湿药和第一种TNF拮抗剂加两种或多种常规合成的疾病缓解性风湿性药物治疗中的比较疗效

Effect of Adherence to Protocolized Targeted Intensifications of Disease-modifying Antirheumatic Drugs on Treatment Outcomes in Rheumatoid Arthritis: Results from an Australian Early Arthritis Cohort

摘要

著录项

相似文献

相关主题

期刊订阅